Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GSK2193874 was identified as a selective, orally active TRPV4 blocker.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 36.00 | |
2 mg | In stock | $ 52.00 | |
5 mg | In stock | $ 74.00 | |
10 mg | In stock | $ 129.00 | |
25 mg | In stock | $ 259.00 | |
50 mg | In stock | $ 426.00 | |
100 mg | In stock | $ 633.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 113.00 |
Description | GSK2193874 was identified as a selective, orally active TRPV4 blocker. |
Targets&IC50 | TRPV4 (human):40 nM (IC50), TRPV4 (rat):2 nM (IC50) |
In vitro | GSK2193874 was identified as a selective, orally active TRPV4 blocker that inhibits Ca(2+) influx through recombinant TRPV4 channels and native endothelial TRPV4 currents[1,2]. |
In vivo | In isolated rodent and canine lungs, TRPV4 blockade prevented the increased vascular permeability and resultant pulmonary edema associated with elevated PVP. ?In both acute and chronic HF models, GSK2193874 pretreatment inhibited the formation of pulmonary edema and enhanced arterial oxygenation[2]. |
Animal Research | Adult male Sprague-Dawley rats (n = 7 to 8 per group) were treated with vehicle (6% Cavitron) or GSK2193874 (30 mg/kg/day) via oral gavage for at least 4 days before osmotic challenges.?Rats underwent acute and chronic hyper- and hypo-osmotic challenges.Sprague-Dawley (control, n = 18) and spontaneously hypertensive rats (n = 11) were implanted with Data Sciences International (DSI) radiotelemetry transmitters.?Rats were dosed with GSK2193874, and data were captured with DSI receivers and analyzed with Microsoft Excel[2]. |
Molecular Weight | 691.62 |
Formula | C37H38BrF3N4O |
CAS No. | 1336960-13-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 100 mg/mL (144.59 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GSK2193874 1336960-13-4 Membrane transporter/Ion channel TRP/TRPV Channel inhibit Transient receptor potential channels Inhibitor TRP Channel GSK-2193874 GSK 2193874 inhibitor